Ingmar Gorman
PhD, clinical psychologist; co-founder of Fluence and former site co-principal investigator in MAPS MDMA-assisted therapy trials
Key Impact
He is a prominent clinician-researcher in psychedelic-assisted therapy and harm reduction, with work spanning MDMA-assisted psychotherapy for PTSD and models for psychedelic integration in clinical practice.
Background & Research
Ingmar Gorman earned his doctorate in clinical psychology from the New School for Social Research and completed his clinical training at Bellevue Hospital Center. His work focuses on psychedelic-assisted therapy, harm reduction, and integration, and he has been involved as a site co-principal investigator in MAPS Phase 3 MDMA-assisted therapy research for PTSD. He also serves as Director of the Psychedelic Education and Continuing Care Program at the Center for Optimal Living and is associated with Fluence, a psychedelic education and training organization.
Collaboration Network
30 collaborators· click a node to visit their profile
Full network →